DUBLIN, July 14, 2021 /PRNewswire/ — The “Global Drug Discovery Outsourcing (DDO) Market – Forecast to 2030” report has been added to ResearchAndMarkets.com’s providing.
This report caters to the necessity of Contract analysis organizations, Pharmaceutical/Biotech corporations, Academic institutes, Individual researchers, Investors, Service suppliers and different related stake holders to determine and analyze the potential of the DDO market.
This report covers in-depth evaluation of main gamers by therapeutic space of focus, capabilities, geographic presence, enterprise fashions, financials, collaborations, acquisitions, varied advertising methods adopted together with insightful evaluation on conferences, clusters and match making web sites.
Over the final twenty years, the Pharmaceutical business has seen a radical change. The unprecedented downsizing of the interior discovery of huge prescription drugs, patent expiration, and shift in the direction of biologics have seen a surge within the externalization and outsourcing actions.
As the business is searching for new sources of discovery and innovation with restricted assets, there’s a rising choice to maneuver in the direction of externalization and willingness to embrace the idea of outsourcing.
Around 25 – 35% of the worldwide pharmaceutical corporations R&D spending goes into drug discovery outsourcing. Almost all the main Pharmaceutical corporations are contemplating outsourcing as a core technique to fill their discovery pipelines. Contract Research Organisation (CRO) which have exact capabilities by way of higher flexibility are the popular ones. Now-a-days, the massive pharma depends extra on CRO’s for drug discovery capabilities to refill their pipelines.
The world pharmaceutical outsourcing market (Discovery, Preclinical & Clinical Services) is estimated to be $50 – 70 billion in 2020, which accounts to 25 – 40% of the general pharma R&D spending. Out of $50 – 70 billion, 30 – 40% accounts for discovery-based service i.e. $20 – 30 billion in 2020. Pre scientific and Clinical associated providers accounts to 10 – 20% and 40 – 60% respectively.
The report covers all segments, world tendencies and rising methods of the outsourcing market associated to drug discovery. Major Drug Discovery Outsourcing (DDO) gamers included within the report are AMRI, Aragen Lifesciences (GVK Bio), Aurigene Discovery, Bioduro-Sundia, Charles River Laboratories (CRL), ChemPartner, Eurofins, Evotec, Jubilant Biosys, Pharmaron, Sai Lifesciences, Shanghai Medicilon, Syngene, Selvita S.A., Sygnature Discovery, TCG Lifesciences, VIVA Biotech, WuxiApptec and Wuxi Biologics.
The report additionally offers insights on buyer base, quantity of offers between CRO’s and Pharmaceutical /biotech corporations, world FTE charges, worker power & quantity of corporations, income per worker of main gamers, therapeutic space hole evaluation and profitable analysis collaboration outcomes of chosen CRO’s and Sponsors, that are more likely to have an effect on the DDO market within the foreseeable future.
Key Topics Covered:
1 Introduction
2 Market Analysis2.1 Research Methodology2.2 Forecasting Model2.3 Market Dynamics2.4 Market Sizing2.5 Trends & Strategies within the CRO Industry2.6 Impact of COVID-19 on the CRO Industry
3 Business Overview3.1 Business Models3.2 Business Evolution3.3 Certifications3.4 DD Indicators3.5 Pharmaceutical R&D Exp & Intensity3.6 Pharmaceutical Therapeutic Area Analysis3.7 Selected Pharmaceutical Players-Area of Interest
4 Competitor Analysis4.1 Therapeutic Area Matrix4.2 Global FTE Rates4.3 Regional Revenues vs FTE4.4 Customer Base4.5 Deals4.6 Therapeutic Area Analysis4.7 Therapeutic Area Gap Analysis4.8 Selected CRO Track Record of Success & Distinguished Core Capabilities4.9 Start-Up CROs & Their Differentiated Area of Expertise4.10 Pricing Analysis of Various Drug Discovery Services4.11 Successful Collaborations
5 Leading Players5.1 Overview5.2 Capabilities5.3 Therapeutic Area5.4 Business Models5.5 Collaborations5.6 Acquisitions
6 Marketing Strategies6.1 Conferences6.1.1 Conferences -2018, 2019, 2020, 20216.1.2 Conference Analysis- 2018, 2019, 20206.2 Match Making Websites6.3 Virtual Pharmaceuticals6.4 Online RPFs6.5 Networking Websites6.6 Clusters6.7 Other Marketing Strategies6.7.1 Website Rankings6.8 References
Companies Mentioned
AMRI
Aragen Lifesciences (GVK Biosciences)
Aurigene Discovery
Bioduro-Sundia
Charles River Laboratories (CRL)
Chempartner
Eurofins
Evotec
Jubilant Biosys
Pharmaron Inc.
Sai Lifesciences
Shanghai Medicilon
Syngene
Selvita SA
Sygnature Discovery
TCG Lifesciences
Viva Biotech
Wuxiapptec
Wuxi Biologics
For extra details about this report go to https://www.researchandmarkets.com/r/sxgh23
Media Contact: Research and Markets Laura Wood, Senior Manager [email protected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904 Fax (outdoors U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com
https://www.prnewswire.com/news-releases/drug-discovery-outsourcing-ddo-market-report-2021-2030-unprecedented-downsizing-of-internal-discovery-of-big-pharmaceuticals-shift-towards-biologics-surges-externalization–outsourcing-activities-301333641.html
